Skip to content

Clinical trials

Active, not recruiting Phase 1 Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Status: Active, not recruiting Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20166
20178
20185
201914
20209
202111
202221
202314
20249
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting104

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
M.D. Anderson Cancer Center5
AbbVie4
AstraZeneca4
Daiichi Sankyo4
Eli Lilly and Company3
Novartis Pharmaceuticals3
Pfizer3
Bayer2
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung104
Melanoma27
Colorectal Neoplasms26
Lung Neoplasms25
Squamous Cell Carcinoma of Head and Neck21
Carcinoma, Renal Cell19
Neoplasms19
Ovarian Neoplasms16
Neoplasm Metastasis15
Stomach Neoplasms14

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.